BRUSEL, 20. listopadu 2025 /PRNewswire/ — V rámci Světového týdne povědomí o antimikrobiální rezistenci (AMR) ukazuje zpráva Světové zdravotnické organizace o globálním sledování antibiotické rezistence z roku 2025, že každá šestá bakteriální infekce na světě […]
Tag: Viatris Inc.
Viatris Announces Quarterly Dividend
PITTSBURGH, Nov. 4, 2025 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS) today announced that on November 3, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share […]
Viatris Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141 in Presbyopia
MR-141 Met Primary And All Secondary Endpoints, Demonstrating Rapid And Sustained Improvement In Near Visual Acuity Without Compromising Distance Vision Safety Profile Consistent With Previous Clinical Trials And No Treatment-Related Serious Adverse Events Reported In […]
Viatris Announces Quarterly Dividend
PITTSBURGH, May 7, 2025 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS) today announced that on May 5, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of […]
Viatris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Financial Guidance
PITTSBURGH, Feb. 27, 2025 /PRNewswire/ — Meets 2024 Guidance for Total Revenues, Adjusted […]









